
doi: 10.1007/bf02550314
pmid: 9696337
In order to differentiate benign from malignant prostatic lesions, 42 patients were evaluated using the prostate specific antigen density (PSAD) test. All patients were evaluated with PSA determination, digital rectal examination (DRE), transrectal ultrasonography (TRUS) and ultrasound-guided prostatic biopsies. PSA was analyzed by the I-MX ABBOT assay. PSAD was determined by dividing the serum PSA by the volume of the prostate. Prostatic biopsies identified cancer in 3 of the 42 patients (6.38%). It is concluded that PSAD is valuable for the early diagnosis of localized prostatic carcinoma, especially when there are negative findings from DRE and/or TRUS.
Male, Biopsy, Needle, Prostate, Prostatic Neoplasms, Middle Aged, Prostate-Specific Antigen, Predictive Value of Tests, Biomarkers, Tumor, Humans, Physical Examination, Aged, Ultrasonography
Male, Biopsy, Needle, Prostate, Prostatic Neoplasms, Middle Aged, Prostate-Specific Antigen, Predictive Value of Tests, Biomarkers, Tumor, Humans, Physical Examination, Aged, Ultrasonography
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
